Clinical Trials Logo

Filter by:
NCT ID: NCT06240091 Completed - Depression, Anxiety Clinical Trials

Potency and Precision Investigation

PAPI
Start date: March 13, 2024
Phase: N/A
Study type: Interventional

The overarching goal of this study is to establish initial proof of mechanism for precision interventions in an adult population.

NCT ID: NCT06240065 Enrolling by invitation - Short Gut Syndrome Clinical Trials

Predicting Success With Fiber Food Introduction in Short Bowel Syndrome

Start date: April 19, 2024
Phase: N/A
Study type: Interventional

Short bowel syndrome (SBS) is a rare but challenging condition in which patients have insufficient bowel length to meet fluid, electrolyte, and nutrient requirements without parenteral support. The purpose of this study is to determine how well dietary fiber is tolerated in patients with short bowel syndrome compared to patients without short bowel syndrome based on assessment of gastrointestinal symptoms, and corresponding changes in microbiome composition and metabolomics.

NCT ID: NCT06240052 Recruiting - Clinical trials for Neural Dynamics of the Acquisition and Retention of Fear Learning and Active Avoidance Learning

Use Electroencephalogram to Study Neural Dynamics of Fear Conditioning and Avoidance Learning Circuit in Humans

Start date: February 8, 2024
Phase: N/A
Study type: Interventional

The purpose of this study is to examine which event-related potentials (ERPs) and event-related oscillations (EROs) are associated with fear conditioning, avoidance learning, and memory recall for fear and avoidance, where are the source generators of the observed scalp EEG activity, the impact of fear and avoidance learning on the decision to avoid or not to avoid conditioned stimuli , to examine the large-scale functional connectivity across distributed brain regions across experimental phases, and to examine whether spontaneous EEG data during resting-state correlate with the EEG measures during experimental tasks.

NCT ID: NCT06239961 Not yet recruiting - HIV Clinical Trials

Behavioral Activation, Nutrition, and Activity Intervention

Start date: August 6, 2024
Phase: N/A
Study type: Interventional

This study will explore if a behavioral intervention program to assist people aged 50 and older with HIV is practical. The program includes a coach who talks with participants, encouraging them to be more active, reduce loneliness, and eat healthier.

NCT ID: NCT06239896 Recruiting - Clinical trials for Advance Care Planning

Advance Care Planning With Formerly Homeless Older Adults Residing in Permanent Supportive Housing

ACP-PSH
Start date: March 6, 2024
Phase: N/A
Study type: Interventional

The homeless population is aging, with an increasing proportion of individuals over age 50 who experience accelerated aging, high rates of mortality, and a high risk of not having their wishes honored at the end of life. The goal of this randomized control trial (RCT) is to test the effectiveness of adapted evidence-based advance care planning (ACP) interventions for formerly chronically homeless older adults living in permanent supportive housing (PSH).

NCT ID: NCT06239844 Enrolling by invitation - Asthma in Children Clinical Trials

Navigating Together for Equitable Asthma Management for Children in Families Who Communicate in Language Other Than English

Nav-TEAM
Start date: September 1, 2024
Phase: N/A
Study type: Interventional

The Nav-Team study reviews how well the asthma navigators/coordinator program can improve the lives of asthmatic children, and their caregivers, by providing additional assistance and education. Aim 1 of the study will partner with immigrant serving community organizations to hold meetings that will help tailor the programs. Aim 2 of the study looks at data to help see if the program is working to help children and their caregivers. Aim 2a looks at difference in emergency department use between families that did not use the Nav-Team program and those that did. Aim 2b reviews how well the Nav-Team program did with reaching and connecting with the asthma child and caregiver community. Aim 2b, also reviews the costs of the program, how well the program did will sticking to the program goals, and how well the staff was able to keep up with providing education and help.

NCT ID: NCT06239831 Recruiting - Hypoxemia Clinical Trials

Postoperative Respiratory and Activity Monitoring

Start date: December 22, 2022
Phase:
Study type: Observational

This study plans to learn more about specific breathing and activity recommendations for patients after surgery. Participants will be monitored after abdominal surgery to identify what activities help them breathe better and reduce complications after surgery.

NCT ID: NCT06239818 Recruiting - Clinical trials for Sports-related Concussion

Assessing the Effects of Photobiomodulation on Clinical Recovery From Concussion in Adolescents

Start date: April 17, 2024
Phase: N/A
Study type: Interventional

The purpose of this study is to compare effects of Photobiomodulation therapy (PBMt) to standard of care in adolescent athletes at risk for delayed recovery from subacute sports concussion, to substantiate the impact of subacute PBMt over time on functional and structural connectivity of the brain using advanced MRI sequences and to correlate the psychological and behavioral outcomes to neuroimaging findings

NCT ID: NCT06239792 Recruiting - Sleep Clinical Trials

Sleep Promotion Program Primary Care (SPP PC) Open Trial

SPP OT
Start date: May 13, 2024
Phase: N/A
Study type: Interventional

Investigators developed a brief, scalable, behavioral Sleep Promotion Program (SPP) for adolescents with short sleep duration and sleep-wake irregularity, which relies on one individual session and smart phone technology to deliver evidence-based strategies. This open trial portion of the R34 will focus on conducting an open trial (n=8) to iteratively refine provider training, implementation procedures, and SPP program, per participant and staff feedback.

NCT ID: NCT06239766 Completed - Breast Cancer Clinical Trials

BC Risk Assessment Before Top Surgery

Start date: March 15, 2023
Phase:
Study type: Observational

The population of transgender and gender-diverse (TGD) persons in Wisconsin and the U.S. is steadily increasing. As this population grows, the number of individuals seeking gender-affirming therapies, including gender-affirming operations and gender-affirming hormone therapy, is also growing. An example of gender-affirming surgery is chest masculinization surgery, in which most breast tissue is removed in a person assigned female or intersex at birth to allow the chest to appear masculine. Gender-affirming chest masculinization surgery is not generally considered equivalent to an oncologic mastectomy, which aims to removal all breast tissue for future breast cancer reduction or current breast cancer treatment. The goals of this investigation are to 1) determine the percent of TGD persons considering chest masculinization surgery who have an elevated lifetime risk of breast cancer development and/or a pathogenic genetic mutation; 2) measure the percent who are at risk and choose to undergo risk-reducing mastectomies as part of chest masculinization surgery; and 3) assess and compare self-perceived breast cancer risk with calculated risk. The results of this study will substantially inform TGD patients and surgeons on the utility of personalized breast cancer risk assessment prior to chest masculinization surgery and the accuracy of self-perceived breast cancer risk in TGD persons.